The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hadas Nicole R. since 2014.
This trader's CIK number is 1602396.
At the time of last reporting, Hadas Nicole R. was the SVP, Chief Legal Officer of Akebia Therapeutics, Inc.. (stock ticker symbol AKBA).
Also see all insider trading activities at Akebia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | AKBA | 0 | $0 | 25,401 | $35,842 | 0 | $0 |
| 2023 | AKBA | 0 | $0 | 82,897 | $94,147 | 0 | $0 |
| 2022 | AKBA | 0 | $0 | 21,062 | $45,620 | 0 | $0 |
| 2021 | AKBA | 0 | $0 | 15,345 | $52,115 | 0 | $0 |
| 2020 | AKBA | 0 | $0 | 7,050 | $61,334 | 0 | $0 |
| 2017 | AKBA | 0 | $0 | 12,723 | $209,884 | 0 | $0 |
| 2016 | AKBA | 0 | $0 | 6,480 | $62,439 | 0 | $0 |
| 2015 | AKBA | 0 | $0 | 6,166 | $60,152 | 0 | $0 |
| 2014 | AKBA | 3,500 | $59,500 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-13 | AKBA | Sale | 12,016 | 1.26 | 15,140 |
| 2024-02-29 | AKBA | Sale | 5,974 | 1.58 | 9,438 |
| 2024-02-27 | AKBA | Sale | 7,411 | 1.52 | 11,264 |
| 2023-05-25 | AKBA | Sale | 63,186 | 1.22 | 77,276 |
| 2023-03-01 | AKBA | Sale | 13,034 | .88 | 11,443 |
| 2023-02-27 | AKBA | Sale | 6,677 | .81 | 5,428 |
| 2022-03-01 | AKBA | Sale | 14,507 | 2.17 | 31,494 |
| 2022-02-28 | AKBA | Sale | 6,555 | 2.15 | 14,126 |
| 2021-04-01 | AKBA | Sale | 1,060 | 3.40 | 3,604 |
| 2021-03-01 | AKBA | Sale | 14,285 | 3.40 | 48,511 |
| 2020-02-28 | AKBA | Sale | 7,050 | 8.70 | 61,334 |
| 2017-10-02 | AKBA | Sale | 7,803 | 19.80 | 154,460 |
| 2017-07-03 | AKBA | Sale | 1,554 | 14.26 | 22,156 |
| 2017-04-03 | AKBA | Sale | 1,556 | 9.18 | 14,280 |
| 2017-01-01 | AKBA | Sale | 1,810 | 10.49 | 18,988 |
| 2016-10-01 | AKBA | Sale | 1,556 | 8.96 | 13,933 |
| 2016-07-05 | AKBA | Sale | 1,557 | 7.47 | 11,626 |
| 2016-04-04 | AKBA | Sale | 1,556 | 9.41 | 14,641 |
| 2016-01-04 | AKBA | Sale | 1,811 | 12.28 | 22,239 |
| 2015-10-02 | AKBA | Sale | 1,484 | 8.67 | 12,860 |
| 2015-07-02 | AKBA | Sale | 1,484 | 9.54 | 14,160 |
| 2015-04-02 | AKBA | Sale | 1,483 | 9.09 | 13,477 |
| 2015-01-02 | AKBA | Sale | 1,715 | 11.46 | 19,655 |
| 2014-03-25 | AKBA | Buy | 3,500 | 17.00 | 59,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hadas Nicole R. (SVP, Chief Legal Officer of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.